Genome-Wide CRISPR Analysis Uncovers Metformin and NSAID Combination as a Chemopreventive Approach in Smoking-Associated Oral Cancer.

Yamada HY, Rao CV

Open source

DOI
10.1158/1940-6207.capr-26-0004
Published
2026 Apr 1
Container
Cancer prevention research (Philadelphia, Pa.)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1940-6207.capr-26-0004,
  title = {Genome-Wide CRISPR Analysis Uncovers Metformin and NSAID Combination as a Chemopreventive Approach in Smoking-Associated Oral Cancer.},
  author = {Yamada HY and Rao CV},
  year = {2026},
  journal = {Cancer prevention research (Philadelphia, Pa.)},
  doi = {10.1158/1940-6207.capr-26-0004},
  url = {https://doi.org/10.1158/1940-6207.capr-26-0004}
}

RIS

TY  - JOUR
TI  - Genome-Wide CRISPR Analysis Uncovers Metformin and NSAID Combination as a Chemopreventive Approach in Smoking-Associated Oral Cancer.
AU  - Yamada HY
AU  - Rao CV
PY  - 2026
JO  - Cancer prevention research (Philadelphia, Pa.)
DO  - 10.1158/1940-6207.capr-26-0004
UR  - https://doi.org/10.1158/1940-6207.capr-26-0004
ER  - 

APA

HY, Y., & CV, R. (2026). Genome-Wide CRISPR Analysis Uncovers Metformin and NSAID Combination as a Chemopreventive Approach in Smoking-Associated Oral Cancer.. Cancer prevention research (Philadelphia, Pa.). https://doi.org/10.1158/1940-6207.capr-26-0004

Source records